A Cannabinoid (CBD) Focused Company
Refuel – Recovery – Relief – Relax
MIAMI, FL, UNITED STATES, February 11, 2019 /EINPresswire.com/ — Chill Protein CBD LLC (Chill Protein or the Company), a health product company focused on the Cannabinoid (CBD) market, announced that on January 29, 2019, the Nasdaq approved the reservation for the ticker symbol CCBD. The ticker symbol will be reserved for twenty four months from the date approved. Chill Protein has not applied to list on Nasdaq and that Nasdaq has not yet considered whether the company is qualified to list.
“We are fortunate to have received the ticker approval reservation CCBD,” said Beau Clavijo, President of Chill Protein. “This approval is one of many steps we will need to take as we move forward in building our Company.”
Chill Protein currently offers a protein powder that contains over 26 grams of protein and is rich in branch chain amino acids (BCAA) and glutamine. The blend offers different protein sources and thus has a unique amino acid profile and provides a sustained-release protein blend, that powers and fuels your muscles. Chill Protein's CBD is made under precise manufacturing techniques and provides a consistent and powerful product.
Chill Protein advises the following: to use its products responsibly; before using this product consult a physician; may interact with other drugs; statements made about this product have not been evaluated by the Food and Drug Administration; and our products are not intended to diagnose, treat, cure or prevent disease.
Chill Protein CBD, LLC
For Further inquiries please email us at:
CHILL PROTEIN CBD
Source: EIN Presswire